chr16-56191219-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000665141.2(GNAO1-DT):​n.47+344C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0169 in 146,716 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.017 ( 55 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GNAO1-DT
ENST00000665141.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.428

Publications

0 publications found
Variant links:
Genes affected
GNAO1-DT (HGNC:27543): (GNAO1 divergent transcript)
GNAO1 (HGNC:4389): (G protein subunit alpha o1) The protein encoded by this gene represents the alpha subunit of the Go heterotrimeric G-protein signal-transducing complex. Defects in this gene are a cause of early-onset epileptic encephalopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
GNAO1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • movement disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • neurodevelopmental disorder with involuntary movements
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0534 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNAO1-DTNR_027078.2 linkn.-125C>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNAO1-DTENST00000665141.2 linkn.47+344C>A intron_variant Intron 1 of 3
GNAO1ENST00000714052.1 linkn.102-1039G>T intron_variant Intron 1 of 2
GNAO1-DTENST00000715694.1 linkn.1976+1324C>A intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0169
AC:
2479
AN:
146610
Hom.:
55
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0553
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00899
Gnomad ASJ
AF:
0.00295
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00968
Gnomad NFE
AF:
0.000653
Gnomad OTH
AF:
0.0158
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
16
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
12
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
16
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0169
AC:
2486
AN:
146716
Hom.:
55
Cov.:
31
AF XY:
0.0164
AC XY:
1168
AN XY:
71436
show subpopulations
African (AFR)
AF:
0.0553
AC:
2264
AN:
40924
American (AMR)
AF:
0.00898
AC:
133
AN:
14810
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
10
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5000
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8670
Middle Eastern (MID)
AF:
0.0104
AC:
3
AN:
288
European-Non Finnish (NFE)
AF:
0.000653
AC:
43
AN:
65870
Other (OTH)
AF:
0.0157
AC:
32
AN:
2044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
124
249
373
498
622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000323
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.6
DANN
Benign
0.77
PhyloP100
0.43
PromoterAI
-0.073
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs537395792; hg19: chr16-56225131; API